Akèy › Kondisyon po
Etid klinik pou Kondisyon po ap rekrite nan Etazini
22 etid pou Kondisyon po ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Indianapolis, IN4 etid
- Portland, OR4 etid
- Hollywood, FL4 etid
- Los Angeles, CA4 etid
- Phoenix, AZ4 etid
- Minneapolis, MN3 etid
- Saint Joseph, MO3 etid
- Miami, FL3 etid
- Columbus, OH3 etid
- Chicago, IL3 etid
- Arlington Heights, IL3 etid
- Santa Clarita, CA3 etid
- New York City, NY3 etid
- Fargo, ND3 etid
- Tampa, FL3 etid
- Boston, MA3 etid
Pa eta
- Alabama3 etid
- Arizona5 etid
- Florid8 etid
- Georgia5 etid
- Illinois7 etid
- Indiana5 etid
- Kalifòni11 etid
- Maryland4 etid
- Massachusetts3 etid
- Minnesota3 etid
- Missouri4 etid
- New York5 etid
- North Carolina4 etid
- North Dakota3 etid
- Ohio3 etid
- Oregon4 etid
- Pennsylvania3 etid
- South Carolina5 etid
- Tennessee3 etid
- Texas5 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis
Ap rekriteEtid obsèvasyon
Laj 10 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07033169Effects of Treatments on Atopic Dermatitis
Ap rekriteFaz 2Volontè an sante akeyi
Laj 2 a 50 · Tout sèks · Mizajou Sep 28, 2026 · NCT01631617Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Day – 100 Years · Tout sèks · Mizajou Sep 22, 2026 · NCT02471352Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Ap rekriteFaz 1
Laj 12 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07049575(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04996875A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 8, 2026 · NCT05723198A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599813OCT Vibrography for Biomechanical Properties of Tissues
Ap rekriteVolontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Aug 19, 2026 · NCT05759780A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
Ap rekriteFaz 2
Laj 2 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT07027345A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
Laj 18 a 74 · Tout sèks · Mizajou Aug 12, 2026 · NCT07037901A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease
Ap rekriteFaz 1 bonè
Laj 12 ak plis · Tout sèks · Mizajou Jul 21, 2026 · NCT07717346A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT07115745Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders
Ap rekriteFaz 1 bonè
6 Months · Tout sèks · Mizajou May 1, 2026 · NCT05649098Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Apr 22, 2026 · NCT07144852Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Apr 22, 2026 · NCT07144345Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 16 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT00842283Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 16, 2025 · NCT07213154Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 27, 2024 · NCT06674980Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting
Ap rekrite
Tout laj · Tout sèks · Mizajou Dec 9, 2024 · NCT06724627Collection and Distribution of Biospecimens for Novel Research Uses
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Month – 89 Years · Tout sèks · Mizajou Nov 9, 2022 · NCT03848962Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2022 · NCT04684602Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.